Nucleus Network is Australia’s premier dedicated early-stage clinical trial organization, conducting 100+ Phase 1 clinical trials annually, 50% of which are true first-in-human programs. Operating units in the three largest cities in Australia (Melbourne, Sydney, Brisbane), Nucleus Network has recruitment access to 80% of the country’s population. Additionally, Nucleus Network operates a phase 1 unit in the USA (Minnesota), which has significant experience in Renal Impairment studies.